JBIO
Jade Biosciences, Inc. (JBIO) reported net income of -$127.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$127.41M | -83.0% |
| FY 2024 | -$69.63M | +7.8% |
| FY 2023 | -$75.52M | -46.6% |
| FY 2022 | -$51.51M | -124.3% |
| FY 2021 | -$22.96M | -138.9% |
| FY 2020 | -$9.61M | - |
Jade Biosciences, Inc. (JBIO) reported net income of -$127.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Jade Biosciences, Inc.'s net income declined from -$9.61M to -$127.41M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.